Search research articles
Contact Us
Filters
Showing results (1-10 of 204) with videos related to
Page
of 21
Sort By:
Current Opinion in Infectious Diseases
|
April 20, 2002
Current and future approaches to antifungal therapy
Thomas F. Patterson
The Pediatric Infectious Disease Journal
|
June 12, 2003
Combination antifungal therapy
Thomas F Patterson
Transactions of the American Clinical and Climatological Association
|
June 21, 2011
Clinical utility and development of biomarkers in invasive aspergillosis
Thomas F Patterson
Medical Mycology
|
November 10, 2018
Treatment of invasive aspergillosis: Polyenes, echinocandins, or azoles?
Thomas F Patterson
Current Opinion in Infectious Diseases
|
June 25, 2003
Early use of antifungal therapy in high-risk patients
Thomas F Patterson
Current Infectious Disease Reports
|
October 27, 2006
The role of echinocandins, extended-spectrum azoles, and polyenes to treat opportunistic moulds and Candida
Thomas F Patterson
Lancet (London, England)
|
September 20, 2005
Advances and challenges in management of invasive mycoses
Thomas F Patterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2002
New agents for treatment of invasive aspergillosis
Thomas F Patterson
Medical Mycology
|
March 3, 2009
Risk stratification for invasive aspergillosis: early assessment of host susceptibility
Thomas F Patterson
Seminars in Respiratory Infections
|
June 19, 2002
Invasive Aspergillus infections in hematologic malignancy patients
Sofia Perea, Thomas F Patterson
Page
of 21
Search research articles
Search
Showing results (1-10 of 204) with videos related to
Sort By:
Page
of 21
Current Opinion in Infectious Diseases
|
April 20, 2002
Current and future approaches to antifungal therapy
Thomas F. Patterson
The Pediatric Infectious Disease Journal
|
June 12, 2003
Combination antifungal therapy
Thomas F Patterson
Transactions of the American Clinical and Climatological Association
|
June 21, 2011
Clinical utility and development of biomarkers in invasive aspergillosis
Thomas F Patterson
Medical Mycology
|
November 10, 2018
Treatment of invasive aspergillosis: Polyenes, echinocandins, or azoles?
Thomas F Patterson
Current Opinion in Infectious Diseases
|
June 25, 2003
Early use of antifungal therapy in high-risk patients
Thomas F Patterson
Current Infectious Disease Reports
|
October 27, 2006
The role of echinocandins, extended-spectrum azoles, and polyenes to treat opportunistic moulds and Candida
Thomas F Patterson
Lancet (London, England)
|
September 20, 2005
Advances and challenges in management of invasive mycoses
Thomas F Patterson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2002
New agents for treatment of invasive aspergillosis
Thomas F Patterson
Medical Mycology
|
March 3, 2009
Risk stratification for invasive aspergillosis: early assessment of host susceptibility
Thomas F Patterson
Seminars in Respiratory Infections
|
June 19, 2002
Invasive Aspergillus infections in hematologic malignancy patients
Sofia Perea, Thomas F Patterson
Page
of 21